Sumitomo Life Insurance’s AbbVie ABBV Stock Holding History

Sumitomo Life Insurance’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.72M	Buy	21,714 +2,400	+12%	+$532K	0.11%	64
2025 Q4	$4.41M	Buy	19,314 +3,954	+26%	+$901K	0.12%	70
2025 Q3	$3.56M	Sell	15,360 -497	-3%	-$101K	0.11%	84
2025 Q2	$2.94M	Sell	15,857 -987	-6%	-$183K	0.2%	88
2025 Q1	$3.53M	Sell	16,844 -361	-2%	-$70.2K	0.13%	75
2024 Q4	$3.06M	Sell	17,205 -9,798	-36%	-$1.8M	0.06%	88
2024 Q3	$5.33M	Buy	27,003 +6,161	+30%	+$1.15M	0.1%	51
2024 Q2	$3.57M	Sell	20,842 -2,723	-12%	-$451K	0.08%	67
2024 Q1	$4.29M	Sell	23,565 -898	-4%	-$155K	0.11%	62
2023 Q4	$3.79M	Sell	24,463 -1,271	-5%	-$185K	0.12%	54
2023 Q3	$3.84M	Sell	25,734 -337	-1%	-$49.5K	0.11%	44
2023 Q2	$3.51M	Sell	26,071 -2,524	-9%	-$370K	0.15%	50
2023 Q1	$4.56M	Sell	28,595 -210	-0.7%	-$32.1K	0.38%	31
2022 Q4	$4.66M	Sell	28,805 -284	-1%	-$43.5K	0.34%	27
2022 Q3	$3.9M	Sell	29,089 -3,531	-11%	-$507K	0.17%	33
2022 Q2	$5M	Buy	32,620 +643	+2%	+$98.3K	0.14%	29
2022 Q1	$5.18M	Sell	31,977 -511	-2%	-$74.2K	0.13%	31
2021 Q4	$4.4M	Sell	32,488 -959	-3%	-$113K	0.1%	41
2021 Q3	$3.61M	Sell	33,447 -1,414	-4%	-$162K	0.1%	51
2021 Q2	$3.93M	Sell	34,861 -5,389	-13%	-$607K	0.12%	45
2021 Q1	$4.36M	Sell	40,250 -11,616	-22%	-$1.24M	0.18%	42
2020 Q4	$5.56M	Sell	51,866 -4,744	-8%	-$456K	0.23%	33
2020 Q3	$4.96M	Sell	56,610 -4,711	-8%	-$444K	0.23%	42
2020 Q2	$6.02M	Buy	61,321 +2,062	+3%	+$182K	0.32%	23
2020 Q1	$4.51M	Buy	59,259 +978	+2%	+$83.3K	0.32%	33
2019 Q4	$5.16M	Buy	58,281 +3,283	+6%	+$273K	0.58%	38
2019 Q3	$4.16M	Buy	54,998 +4,310	+9%	+$295K	0.54%	43
2019 Q2	$3.69M	Buy	50,688 +2,074	+4%	+$163K	0.44%	62
2019 Q1	$3.92M	Sell	48,614 -5,498	-10%	-$450K	0.53%	52
2018 Q4	$4.99M	Sell	54,112 -2,888	-5%	-$254K	0.69%	34
2018 Q3	$5.39M	Sell	57,000 -6,021	-10%	-$571K	0.65%	35
2018 Q2	$5.84M	Buy	63,021 +2,934	+5%	+$287K	0.72%	28
2018 Q1	$5.69M	Sell	60,087 -5,428	-8%	-$596K	0.75%	27
2017 Q4	$6.34M	Buy	65,515 +6,102	+10%	+$575K	0.79%	25
2017 Q3	$5.28M	Buy	59,413 +3,452	+6%	+$263K	0.67%	35
2017 Q2	$4.06M	Buy	55,961 +2,609	+5%	+$175K	0.53%	52
2017 Q1	$3.48M	Sell	53,352 -7,011	-12%	-$441K	0.49%	57
2016 Q4	$3.78M	Sell	60,363 -2,482	-4%	-$152K	0.54%	45
2016 Q3	$3.96M	Sell	62,845 -7,812	-11%	-$506K	0.59%	38
2016 Q2	$4.37M	Sell	70,657 -4,156	-6%	-$253K	0.6%	40
2016 Q1	$4.27M	Sell	74,813 -1,956	-3%	-$109K	0.56%	45
2015 Q4	$4.55M	Buy	76,769 +5,444	+8%	+$314K	0.57%	46
2015 Q3	$3.88M	Buy	71,325 +3,542	+5%	+$231K	0.51%	49
2015 Q2	$4.55M	Sell	67,783 -6,396	-9%	-$418K	0.55%	44
2015 Q1	$4.34M	Sell	74,179 -22,270	-23%	-$1.35M	0.48%	55
2014 Q4	$6.31M	Sell	96,449 -5,347	-5%	-$337K	0.63%	36
2014 Q3	$5.88M	Sell	101,796 -12,768	-11%	-$709K	0.57%	37
2014 Q2	$6.47M	Sell	114,564 -17,992	-14%	-$944K	0.62%	33
2014 Q1	$6.81M	Sell	132,556 -13,714	-9%	-$693K	0.66%	33
2013 Q4	$7.72M	Sell	146,270 -9,314	-6%	-$458K	0.7%	32
2013 Q3	$6.96M	Buy	155,584 +36,386	+31%	+$1.61M	0.65%	35
2013 Q2	$4.93M	Buy	+119,198	New	+$5.21M	0.47%	54

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sumitomo Life Insurance's ABBV Position: Q1 2026 in Review

Sumitomo Life Insurance increased its AbbVie (ABBV) stake by 12% in Q1 2026, buying an estimated $532K and bringing the position to 21,714 shares worth $4.72M. The position accounts for 0.11% of the portfolio, ranked #64.

Sumitomo Life Insurance first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.72M in Q4 2013. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Sumitomo Life Insurance held 21,714 shares of AbbVie worth $4.72M as of Q1 2026.
Sumitomo Life Insurance bought 2,400 AbbVie shares in Q1 2026, an estimated $532K.
AbbVie made up 0.11% of Sumitomo Life Insurance's portfolio in Q1 2026, its #64 holding.
Sumitomo Life Insurance first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Sumitomo Life Insurance's AbbVie position peaked at $7.72M in Q4 2013.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Sumitomo Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.